Financière de Tubize S.A.

Equities

TUB

BE0003823409

Pharmaceuticals

Market Closed - Euronext Bruxelles Other stock markets 09:05:29 12/06/2024 pm IST			5-day change	1st Jan Change
108 ^EUR	+4.05%		+9.53%	+50.63%

27/03	Financière de Tubize SA Announces Board Resignations	CI
16/03	Financière de Tubize SA Proposes Gross Dividend, Payable on 3 May 2024	CI

Financiere de Tubize Reports Earnings Results for the Year 2017

February 22, 2018 at 12:30 pm IST

Financiere de Tubize reported earnings results for the year 2017. For the year, the company reported profit of €72.7 million against €69.0 million in 2016.

Latest news about Financière de Tubize S.A.

Financière de Tubize SA Announces Board Resignations	27/03	CI
Financière de Tubize SA Proposes Gross Dividend, Payable on 3 May 2024	16/03	CI
Financière de Tubize SA Reports Earnings Results for the Full Year Ended December 31, 2023	15/03	CI
Financière de Tubize SA Reports Earnings Results for the Half Year Ended June 30, 2023	29/23/29	CI
Financière de Tubize SA Announces Dividend Approval, Payable as from 5 May 2023	29/23/29	CI
Financière de Tubize SA's Equity Buyback announced on December 1, 2018, has expired.	24/23/24	CI
Financière de Tubize SA Reports Earnings Results for the Full Year Ended December 31, 2022	18/23/18	CI
Financière De Tubize SA Proposes Dividend, Payable on 5 May 2023	25/23/25	CI
Financière de Tubize SA Reports Earnings Results for the Half Year Ended June 30, 2022	29/22/29	CI
Financière de Tubize SA Approves Distribution of Gross Dividend for the Year Ended December 31, 2021, Payable on 5 May 2022	29/22/29	CI
Financière de Tubize SA to Consider the Resignation of Edouard Janssenas as Director	24/22/24	CI
Financière De Tubize Sa Proposes Dividend for 2021, Payable on 5 May 2022	01/22/01	CI
Financière de Tubize SA Reports Earnings Results for the Full Year Ended December 31, 2021	26/22/26	CI
Financière De Tubize Sa Reports Earnings Results for the Second Quarter Ended June 30, 2021	02/21/02	CI
Financière de Tubize SA Approves Dividend, Payable on May 6, 2021	30/21/30	CI
Financière de Tubize SA Proposes Dividend, Payable on 6 May 2021	27/21/27	CI
Financière De Tubize Sa Reports Earnings Results for the Half Year Ended June 30, 2020	27/20/27	CI
Tranche Update on Financière de Tubize SA's Equity Buyback Plan announced on December 1, 2018.	24/20/24	CI
Financière de Tubize SA Reports Earnings Results for the Full Year Ended December 31, 2019	20/20/20	CI
Financière De Tubize Sa Announces Board Changes; Proposes Dividend Payable on 8 May 2020	20/20/20	CI
Tranche Update on Financière de Tubize SA's Equity Buyback Plan announced on December 1, 2018.	20/20/20	CI
Financière De Tubize Sa Reports Earnings Results for the Half Year Ended June 30, 2019	25/19/25	CI
Tranche Update on Financière de Tubize SA's Equity Buyback Plan announced on December 1, 2018.	25/19/25	CI
Financière de Tubize SA Approves Dividend for the Year 2018, Payable on May 6, 2019	25/19/25	CI
Financifre De Tubize Sa Reports Earnings Results for the Full Year Ended December 31, 2018	28/19/28	CI

Chart Financière de Tubize S.A.

Duration

Period

More charts

Company Profile

Financière de Tubize S.A. is a holding company that owns 36.24% of the listed biopharmacy group UCB.

Sector

Pharmaceuticals

Calendar

25/07/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

103.8 EUR

Average target price

134.8 EUR

Spread / Average Target

+29.82%

Consensus

Sector Other Pharmaceuticals

	1st Jan change	Capi.
FINANCIÈRE DE TUBIZE S.A.	+50.63%	4.96B
ELI LILLY AND COMPANY	+48.79%	780B
NOVO NORDISK A/S	+41.76%	627B
MERCK & CO., INC.	+19.43%	334B
ABBVIE INC.	+7.18%	296B
ASTRAZENECA PLC	+17.60%	244B
ROCHE HOLDING AG	-0.41%	217B
NOVARTIS AG	+11.54%	214B
AMGEN INC.	+4.53%	161B
PFIZER, INC.	-3.92%	159B

Other Pharmaceuticals